Executive Interviews
Spotlight Video Series – Life Sciences
Life Science sector represents the essential industry for Wholesale Investor. A great number of small, medium and start-up life science enterprises are directly promoted to active investors and deal makers.
AIMEDICS – CEO Interview
AIMEDICS has developed the HypoMon which is the world’s first non-invasive night time low blood glucose management system. More than 11 million diabetic insulin users in the developed world suffer from bouts of dangerously low blood glucose several nights per month. Independent USA market research indicates that the HypoMon is a unique product addressing a […]
Granite Power – CEO Interview
GPL’S business focus is on delivering generation solutions using GPL’s proven and patented GRANEX® technology, which generates electricity from low-to-medium temperature heat sources, such as industrial recovered waste heat from sources such as generator sets, smelters and other common industrial processes.
Benlee Company – CEO Interview
The Benlee Property Trust No 5 is the 5th trust established by the property manager in the last 3 years. The trust has purchased two Brisbane properties for $7m & $5.5m which were settled on 28 June 2012 by the stage one equity raising of $7.4m and the balance by bank debt.
Trade Saver Group – CEO Interview
Building and renovator group-buying website www.tradesaver.com.au is an Australian owned company offering investors the opportunity to participate in a new and high growth business. Trade Saver is in a unique position, specialising in products and services for the building and construction industries and the highly lucrative renovation market.
Catalyst Medical Australia – CEO Interview
Catalyst Medical was established to develop pathways to commercialise medical device technologies.
Phylogica Limited – CFO Interview
Phylogica Limited (ASX: PYC) is a biotechnology company based in Perth, Australia and Oxford UK, with a world-class drug discovery platform harnessing the rich biodiversity of nature to discover novel peptide therapeutics.
Ringfence Capital Fund – Interview
The Ringfence Capital Fund is a new and unique fund that offers investors exposure to both retail property and business opportunities that provide a strong and secure cashflow with potential for growth through efficient management and value add strategies.
Folkstone – ASX:FLK (CEO Interview)
Folkestone is a real estate investment, development and funds management company listed on the ASX (Code: FLK).
Backed By Leading Investment Groups and Family Offices
